We are actively seeking collaboration opportunities to license our multispecific antibody platform or co-develop exciting multispecific candidate antibody drugs. Please feel free to leave a message to get in touch with us.
- Home
- Contact Us
We are actively seeking collaboration opportunities to license our multispecific antibody platform or co-develop exciting multispecific candidate antibody drugs. Please feel free to leave a message to get in touch with us.
Our ImmuBridge™ platform is specifically designed for developing multispecific antibodies targeting tumor antigens. We provide comprehensive research services for cancer immunotherapy to drive advancements in the field.